companydata.dkcompanydata.dk

BIOVET ApS: Financial statements 2023

CVR: 13228787

Source: annual report 2023, Danish Business Authority

01/05/2022 – 30/04/2023

BIOVET ApS (CVR 13228787) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 3,694,399 and a net result of DKK 94,752,278 compared with DKK 9,802,939 the year before. That is a decrease of 17% compared with the year before. Equity in the 2023 report amounted to DKK 202,110,464. The solvency ratio was 96.4%. The company had 1 employee in the financial year.

Gross Profit
DKK 3,694,399
Profit/Loss
DKK 94,752,278
Equity
DKK 202,110,464
Total Assets
DKK 209,766,285
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-3.7 mio.94.8 mio.202.1 mio.1
2022-4.5 mio.9.8 mio.107.4 mio.1
2021-10.8 mio.3.8 mio.97.6 mio.1
2020-6 mio.2.9 mio.93.8 mio.1
2019-9.4 mio.-12.4 mio.90.8 mio.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Thomas Velin joins BIOVET ApS as adm. dir.Nov 21, 2023

As of November 21, 2023, Thomas Velin is registered as adm. dir. of BIOVET ApS.

About BIOVET ApS

BIOVET ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 1989. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ApS SPKR 4 NR. 2590. The management consists of Thomas Velin and Flemming Velin. The company is owned by NORDVET ApS. The company has 1 employee (2026). In 2026, the company reported a gross profit of DKK 840,557 and a net result of DKK 13,714,147 compared with DKK 5,093,047 the year before. Equity in the 2026 report amounted to DKK 75,088,817.

Source: annual report 2026, Danish Business Authority